Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus.
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
An outbreak of paralytic poliomyelitis occurred in the Dominican Republic (13 confirmed cases) and Haiti (8 confirmed cases, including 2 fatal cases) during 2000-2001. All but one of the patients were either unvaccinated or incompletely vaccinated children, and cases occurred in communities with very low (7 to 40%) rates of coverage with oral poliovirus vaccine (OPV). The outbreak was associated with the circulation of a derivative of the type 1 OPV strain, probably originating from a single OPV dose given in 1998-1999. The vaccine-derived poliovirus associated with the outbreak had biological properties indistinguishable from those of wild poliovirus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The first outbreak of cVDPV was identified in the Dominican Republic and Haiti between 2000 and 2001.”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [91]
In the citing paper
“In general, the VP1 sequences examined from cVDPV isolates differed from parental OPV strains by only 1–3.5%, suggesting that reversion to the attenuated phenotype of Sabin strains occurs with circulation times of 1–4 years [91,92,93,95,100].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [91]
In the citing paper
“As with the other epidemics in Egypt and Hispaniola, VDPV circulated in a province of Madagascar with low OPV coverage (6,7).”
From Recombinant Vaccine–Derived Poliovirus in Madagascar (2003) · cites this paper as [7]
In the citing paper
“Most VDPV strains described as OPV/HEV-C recombinants were isolated in countries in which wild PVs have been eradicated”
From Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar (2007) · cites this paper as [12]
In the citing paper
“The cVDPV had recovered two of the most important biological properties of wild PV: the capacity to cause severe paralytic disease in humans and the capacity for extensive human-to-human transmission.”
From Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence (2011) · cites this paper as [83]
31 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Oberste, M. S., Maher, K., Kilpatrick, D. R., & Pallansch, M. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1941-1948.1999 · Cited by 866
Self-citationStrebel, P. M., Sutter, R. W., Cochi, S. L., Biellik, R. J., Brink, E. W., Kew, O. M., Pallansch, M. A., Orenstein, W. A., & Hinman, A. R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.568 · Cited by 337
Self-citationKawamura, N., Kohara, M., Abe, S., Komatsu, T., Tago, K., Arita, M., & Nomoto, A. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1302-1309.1989 · Cited by 232
NATHANSON, N., & MARTIN, J. R. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112848 · Cited by 214
Antigenic Structure of Picornaviruses
Minor, P. D. (1990) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-75602-3_5 · Cited by 187
Dual Stem Loops within the Poliovirus Internal Ribosomal Entry Site Control Neurovirulence
Gromeier, M., Bossert, B., Arita, M., Nomoto, A., & Wimmer, E. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.958-964.1999 · Cited by 160
Molecular epidemiology of polioviruses
Kew, O. M., Mulders, M. N., Lipskaya, G. Y., da Silva, E. E., & Patlansch, M. A. (1995) · Seminars in Virology · doi:10.1016/s1044-5773(05)80017-4 · Cited by 157
Self-citationDeterminants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine
Bouchard, M. J., Lam, D. H., & Racaniello, V. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4972-4978.1995 · Cited by 140
Comparative study of five methods for intratypic differentiation of polioviruses
van der Avoort, H. G., Hull, B. P., Hovi, T., Pallansch, M. A., Kew, O. M., Crainic, R., Wood, D. J., Mulders, M. N., & van Loon, A. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.10.2562-2566.1995 · Cited by 122
Self-citationLiu, H.-M., Zheng, D.-P., Zhang, L.-B., Oberste, M. S., Pallansch, M. A., & Kew, O. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11153-11161.2000 · Cited by 119
Self-citation
Research works printed but not linked: 5
- Andrus J. K., Strebel P. M., de Quadros C. A., Olive J. M., Bull. WHO 73, 33 (1995).
- Supplementary figures and details of experimental procedures are available on Science Online at www.sciencemag.org/cgi/content/full/1068284/DC1.
- Minor P. D., Curr. Top. Microbiol. Immunol. 161, 121 (1990).
- ___, Morb. Mortal. Wkly. Rep. 50, 41 (2001).
- Wood D. J., Sutter R. W., Dowdle W. R., Bull. WHO 78, 347 (2000).
Cited by
Items 101–200 of 594
Poliovirus serotype-specific VP1 sequencing primers
Kilpatrick, D. R., Iber, J. C., Chen, Q., Ching, K., Yang, S.-J., De, L., Mandelbaum, M., Emery, B. D., Campagnoli, R. P., Burns, C. C., et al. (2011) · Journal of Virological Methods · doi:10.1016/j.jviromet.2011.03.020 · Cited by 75
Self-citationEvolution of Cell Recognition by Viruses: A Source of Biological Novelty with Medical Implications
Baranowski, É., Ruiz-Jarabo, C. M., Pariente, N., Verdaguer, N., & Domingo, E. (2003) · Advances in virus research · doi:10.1016/s0065-3527(03)62002-6 · Cited by 87
“Examples are the expansion of dengue fever and dengue hemorrhagic fever (Gubler, 1998), recent outbreaks of poliomyelitis (Kew et al., 2002), and the appearance of severe acute respiratory syndrome (SARS).”
Dayan, G. H., Thorley, M., Yamamura, Y., Rodríguez, N., McLaughlin, S., Torres, L. M., Seda, A., Carbia, M., Alexander, L. N., Caceres, V., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/508427 · Cited by 73
“neurovirulent vaccine-derived poliovirus (VDPV) [4–8].”
Self-citationMolecular Mechanisms of Poliovirus Variation and Evolution
Agol, V. I. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-26397-7_8 · Cited by 73
Diagnostic Assay Development for Poliovirus Eradication
Gerloff, N., Sun, H., Mandelbaum, M., Maher, C., Nix, W. A., Zaidi, S., Shaukat, S., Seakamela, L., Nalavade, U. P., Sharma, D. K., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01624-17 · Cited by 72
“VDPVs are phenotypically equivalent to WPV and may cause paralysis and circulate in areas with immunity gaps (13, 14).”
BackgroundSelf-citationPoliovirus vaccine—inactivated
Vidor, E. J., & Plotkin, S. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00034-3 · Cited by 80
Thompson, K. M., & Tebbens, R. J. D. (2012) · Expert Review of Vaccines · doi:10.1586/erv.11.195 · Cited by 72
An economic analysis of poliovirus risk management policy options for 2013–2052
Tebbens, R. J. D., Pallansch, M. A., Cochi, S. L., Wassilak, S. G. F., & Thompson, K. M. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1112-8 · Cited by 73
“widespread transmission, and cause outbreaks of circulating vaccine-derived poliovirus (cVDPV) [8, 10–14].”
BackgroundSelf-citationThe polio-eradication programme and issues of the end game
Minor, P. D. (2011) · Journal of General Virology · doi:10.1099/vir.0.036988-0 · Cited by 75
Smura, T., Blomqvist, S., Paananen, A., Vuorinen, T., Sobotová, Z., Buboviča, V., Ivanova, O. E., Hovi, T., & Roivainen, M. (2007) · Journal of General Virology · doi:10.1099/vir.0.82866-0 · Cited by 77
“…is from Sabin strain poliovirus and the nonstructural part is derived from an unknown HEV-C serotype (Arita et al., 2005; Brown et al., 2003; Guillot et al., 2000; Kew et al., 2002; Liu et al., 2003; Rousset et al., 2003; Shimizu et al., 2004; Yang et al., 2003; reviewed by Kew et al., 2005).”
BackgroundFeasibility of Quantitative Environmental Surveillance in Poliovirus Eradication Strategies
Lodder, W. J., Buisman, A., Rutjes, S. A., Heijne, J. C. M., Teunis, P. F. M., & Husman, A. D. R. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.07972-11 · Cited by 78
“In rare cases, the circulation of vaccine-derived polioviruses results in strains with reverted neurovirulence and antigenicity, which may be picked up in sewage months before the first case of poliomyelitis occurs (12, 18, 43, 45).”
BackgroundGlobal health goals: lessons from the worldwide effort to eradicate poliomyelitis
Aylward, R. B., Acharya, A. K., England, S., Agocs, M. M., & Linkins, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14337-1 · Cited by 77
Vaccine-derived poliovirus from long term excretors and the end game of polio eradication
Martín, J. E.-S. (2006) · Biologicals · doi:10.1016/j.biologicals.2006.02.005 · Cited by 74
Polio eradication, cessation of vaccination and re-emergence of disease
Minor, P. D. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro906 · Cited by 69
“Affected countries include Haiti and the Dominican Republic (which together form the island of Hispaniola”
BackgroundChan, H., Xiao, Y., Weldon, W. C., Oberste, S. M., Chumakov, K., & Daniell, H. (2016) · Plant Biotechnology Journal · doi:10.1111/pbi.12575 · Cited by 73
“Outbreak in Haiti and Dominican Republic (Kew et al., 2002) a decade ago led to the discovery of circulating vaccine-derived polioviruses (VDPV) that caused numerous outbreaks of all three serotypes (Diop et al., 2015; Lakhani and Bumb, 2014).”
BackgroundModeling Population Immunity to Support Efforts to End the Transmission of Live Polioviruses
Thompson, K. M., Pallansch, M. A., Tebbens, R. J. D., Wassilak, S. G. F., & Cochi, S. L. (2012) · Risk Analysis · doi:10.1111/j.1539-6924.2012.01891.x · Cited by 70
Self-citationEstimating the Extent of Vaccine-Derived Poliovirus Infection
Wringe, A., Fine, P. E. M., Sutter, R. W., & Kew, O. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003433 · Cited by 68
“1% sequence identity to Sabin 1, suggesting that the initiating OPV dose occurred in late 1998 or early 1999, 18 months before illness onset in the index case[12].”
BackgroundInfluentialSelf-citationMechanisms of genetic variation in polioviruses
Savolainen‐Kopra, C., & Blomqvist, S. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.663 · Cited by 67
“Polio outbreaks caused by circulating VDPVs have occurred in Egypt [96], Haiti and the Dominican Republic [23], Philippines [97], China [98], Indonesia [99], Cambodia [92], Madagascar [100], Myanmar [95] and Nigeria [95].”
BackgroundInfluentialA case for developing antiviral drugs against polio
Collett, M. S., Neyts, J. H., & Modlin, J. F. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.04.002 · Cited by 69
Poliomyelitis Eradication--a Dangerous Endgame
Nathanson, N., & Fine, P. (2002) · Science · doi:10.1126/science.1071207 · Cited by 67
Guo, J., Bolivar-Wagers, S., Srinivas, N., Holubar, M. K., & Maldonado, Y. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.01.018 · Cited by 71
Nikolaidis, M., Mimouli, K., Kyriakopoulou, Z., Tsimpidis, M., Tsakogiannis, D., Markoulatos, P., & Amoutzias, G. D. (2018) · Virology · doi:10.1016/j.virol.2018.10.006 · Cited by 67
Poliovirus vaccine-inactivated
Plotkin, S. A., & Vidor, E. J. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50029-5 · Cited by 70
Li, L., Ivanova, O., Driss, N., Tiongco-Recto, M., da Silva, R., Shahmahmoodi, S., Sazzad, H. M. S., Mach, O., Kahn, A.-L., & Sutter, R. W. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu065 · Cited by 63
Self-citationRecombination in Positive-Strand RNA Viruses
Wang, H., Cui, X., Cai, X., & An, T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.870759 · Cited by 77
Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child
Adu, F., Iber, J. C., Bukbuk, D. N., Gumede, N., Yang, S.-J., Jorba, J. C., Campagnoli, R. P., Sule, W. F., Yang, C.-F., Burns, C. C., et al. (2007) · Virus Research · doi:10.1016/j.virusres.2007.03.009 · Cited by 70
Self-citationReaching the last one per cent: progress and challenges in global polio eradication
Kew, O. M. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.02.006 · Cited by 69
Self-citationOPV Cessation--the Final Step To a "Polio-Free" World
Aylward, R. B., Sutter, R. W., & Heymann, D. L. (2005) · Science · doi:10.1126/science.1115547 · Cited by 63
Self-citationLong-Term Excretion of Vaccine-Derived Poliovirus by a Healthy Child
Martín, J., Odoom, K., Tuite, G., Dunn, G., Hopewell, N., Cooper, G., Fitzharris, C., Butler, K., Hall, W. W., & Minor, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13839-13847.2004 · Cited by 64
“All four residues mutated in most of the known highly evolved type 1 VDPVs either by direct mutation or recombination with another poliovirus or the nonpoliovirus enterovirus (4, 9, 12, 19).”
BackgroundInfluentialPhylogenetic Analysis of Turkey Astroviruses Reveals Evidence of Recombination
Pantin‐Jackwood, M. J., Spackman, E., & Woolcock, P. R. (2006) · Virus Genes · doi:10.1007/s11262-005-6875-3 · Cited by 69
Ehrenfeld, E., Modlin, J. F., & Chumakov, K. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.49 · Cited by 74
Yakovenko, M. L., Cherkasova, E. A., Rezapkin, G. V., Ivanova, O. E., Ivanov, A. P., Eremeeva, T. P., Baykova, O. Y., Chumakov, K. M., & Agol, V. I. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.2641-2653.2006 · Cited by 62
“A high degree of nucleotide sequence divergence of some vaccine-derived (VDPV) poliovirus strains isolated from paralytic cases as well as from healthy individuals and environments (5, 7, 10, 11, 27 , 29, 37, 38, 55, 58, 59, 69, 71) suggests that they might have circulated in communities for years.”
BackgroundDowdle, W., Van Der Avoort, H., De Gourville, E., Delpeyroux, F., Desphande, J., Hovi, T., Martin, J., Pallansch, M., Kew, O., & Wolff, C. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00844.x · Cited by 61
“(88) However, outbreaks of circulating cVDPV(30,31,102,231) suggest that in some populations with low immunity and no WPV circulation, VDPV could persist indefinitely.”
BackgroundSelf-citationBest, J. M., Castillo‐Solórzano, C., Spika, J. S., Icenogle, J. P., Glasser, J. W., Gay, N. J., Andrus, J. K., & Arvin, A. M. (2005) · The Journal of Infectious Diseases · doi:10.1086/497607 · Cited by 61
“The discovery that vaccine-derived poliovirus recombinants can circulate and cause poliomyelitis contributed to understanding a poliomyelitis outbreak in Hispaniola that started during 2000 [36].”
Lessons from the eradication of smallpox: an interview with D. A. Henderson
Henderson, D. A., & Klepac, P. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0113 · Cited by 66
“While vaccine-derived type 1 and type 3 polioviruses only rarely cause small outbreaks and seem to die out in the environment [27,28], type 2 poliovirus is puzzling.”
BackgroundEvidence of recombination in natural populations of hepatitis A virus
Costa‐Mattioli, M., Ferré, V., Casañe, D., Perez-Bercoff, R., Coste‐Burel, M., Imbert‐Marcille, B., Andre, E. C. M., Bressollette‐Bodin, C., Billaudel, S., & Cristina, J. (2003) · Virology · doi:10.1016/s0042-6822(03)00109-0 · Cited by 63
“Recombination in poliovirus or enterovirus (even between enterovirus; Kew et al., 2002) was first reported to occur outside the capsid region (Cuervo et al., 2001; Guillot et al., 2000; Kew et al., 2002; Kew and Nottay, 1984; Liu et al., 2000).”
BackgroundAntiviral drug discovery: Ten more compounds, and ten more stories (part B)
Clercq, E. D. (2009) · Medicinal Research Reviews · doi:10.1002/med.20149 · Cited by 69
Holmblat, B., Jégouic, S., Muslin, C., Blondel, B., Joffret, M., & Delpeyroux, F. (2014) · mBio · doi:10.1128/mbio.01119-14 · Cited by 62
“Interest in these mechanisms has recently been stimulated by the emergence of circulating vaccinederived strains of PV (cVDPVs), which have been implicated in poliomyelitis outbreaks (3, 4).”
BackgroundHomologous recombination is apparent in infectious bursal disease virus
He, C.-Q., Ma, L., Wang, D., Li, G., & Ding, N. (2008) · Virology · doi:10.1016/j.virol.2008.11.009 · Cited by 58
Productive Homologous and Non-homologous Recombination of Hepatitis C Virus in Cell Culture
Scheel, T. K. H., Galli, A., Li, Y., Mikkelsen, L. S., Gottwein, J. M., & Bukh, J. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003228 · Cited by 59
“due to recombination of vaccine strains with related viruses [6,7]; this remains a problem in poliovirus eradication.”
Comparative genomics of streptococcal species.
Ferretti, J. J., Ajdic, D., & McShan, W. M. (2004) · PubMed · Cited by 62
Cherkasova, E. A., Yakovenko, M. L., Rezapkin, G. V., Korotkova, E. A., Ivanova, O. E., Eremeeva, T. P., Krasnoproshina, L. I., Romanenkova, N. I., Rozaeva, N. R., Sirota, L., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1062-1070.2005 · Cited by 55
“Another significant risk of the prolonged persistence and circulation of VDPVs was demonstrated by recent outbreaks of poliomyelitis in Egypt (43), Dominican Republic and Haiti (21), Philippines (7), and Madagascar (37) caused by circulating VDPV (cVDPV) strains that fully regained their virulence and the ability to s…”
BackgroundSutter, R. W., Kew, O. M., Cochi, S. L., & Aylward, R. B. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00035-5 · Cited by 85
Self-citationPreventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame
Pons-Salort, M., Burns, C. C., Lyons, H. M., Blake, I. M., Jafari, H. S., Oberste, M. S., Kew, O. M., & Grassly, N. C. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005728 · Cited by 60
Self-citationGenetic Relationship between Cocirculating Human Enteroviruses Species C
Bessaud, M., Joffret, M.-L., Holmblat, B., Razafindratsimandresy, R., & Delpeyroux, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024823 · Cited by 55
“Genetic exchanges between PV and other HEV-C have been widely documented [12,13,14,15,16,17,18,19] but those between non-PV HEV-C remain poorly described.”
BackgroundChumakov, K., & Ehrenfeld, E. (2008) · Clinical Infectious Diseases · doi:10.1086/593310 · Cited by 58
“VACCINES • CID 2008:47 (15 December) • 1589 polio outbreak in the Dominican Republic and Haiti that was caused by a recombinant virus derived from a Sabin 1 (vaccine) strain and an unidentified enterovirus [15].”
Martín, J. E.-S., Crossland, G., Wood, D. J., & Minor, P. D. (2003) · Journal of General Virology · doi:10.1099/vir.0.19088-0 · Cited by 54
“More recently, two unrelated outbreaks of type 1 poliomyelitis in the island of Hispaniola (Kew et al., 2002) and in the Philippines (Anon.”
BackgroundNEW MICROBIOLOGY TOOLS FOR PUBLIC HEALTH AND THEIR IMPLICATIONS
Robertson, B. H., & Nicholson, J. K. A. (2004) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.26.021304.144522 · Cited by 54
Coxsackieviruses and Quasispecies Theory: Evolution of Enteroviruses
Domingo, E., Martín, V., Perales, C., & Escarmís, C. (2008) · Springer eBooks · doi:10.1007/978-3-540-75546-3_1 · Cited by 65
Multiple recombinant dengue type 1 viruses in an isolate from a dengue patient
Aaskov, J., Buzacott, K., Field, E. J., Lowry, K., Berlioz-Arthaud, A., & Holmes, E. C. (2007) · Journal of General Virology · doi:10.1099/vir.0.83122-0 · Cited by 52
“…(Ledinko, 1963) and inter-serotypic (Minor et al., 1986; Tolskaya et al., 1983) recombination, as well as inter-species recombination (Kew et al., 2002), there has been considerable debate about whether recombination occurs in DENV (Rico-Hesse, 2003) and the relevance of any…”
High Frequency of Human Enterovirus Species C Circulation in Madagascar
Rakoto-Andrianarivelo, M., Rousset, D., Razafindratsimandresy, R., Chevaliez, S., Guillot, S., Balanant, J., & Delpeyroux, F. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.242-249.2005 · Cited by 53
“Studies of vaccine-derived poliovirus outbreaks, including the one that recently occurred in Madagascar, have shown that all of the implicated strains resulted from recombination between vaccine poliovirus and unidentified wild polioviruses or HEV-C (5, 15, 29, 35).”
BackgroundSynthetic DNA vaccine strategies against persistent viral infections
Villarreal, D. O., Talbott, K. T., Choo, D. K., Shedlock, D. J., & Weiner, D. B. (2013) · Expert Review of Vaccines · doi:10.1586/erv.13.33 · Cited by 56
Oliver, S. L., Brown, D., Green, J., & Bridger, J. C. (2004) · Virology · doi:10.1016/j.virol.2004.06.010 · Cited by 61
Polio eradication at the crossroads
Chumakov, K., Ehrenfeld, E., Agol, V. I., & Wimmer, E. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00205-9 · Cited by 60
Campbell, A. L., & Herold, B. C. (2005) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2005.00351.x · Cited by 51
“The OPV is contraindicated in immunosuppressed children and their household contacts as the vaccine virus may replicate in the gut and cause vaccine associated paralytic poliomyelitis (37, 38).”
BackgroundIntragenic Recombination as a Mechanism of Genetic Diversity in Bluetongue Virus
He, C.-Q., Ding, N., He, M., Li, S., Wang, X., He, H., Liu, X.-F., & Guo, H.-S. (2010) · Journal of Virology · doi:10.1128/jvi.00889-10 · Cited by 50
“Indeed, polio epidemics in Hispaniola that arose from similar recombinants involving vaccine virus and other endogenous enteroviruses have been threatening the entire World Health Organization polio eradication program (23).”
BackgroundImmunization Against Poliomyelitis and the Challenges to Worldwide Poliomyelitis Eradication
Modlin, J. F., Bandyopadhyay, A. S., & Sutter, R. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa622 · Cited by 49
Self-citationADAR Editing in Viruses: An Evolutionary Force to Reckon with
Piontkivska, H., Wales-McGrath, B. D., Miyamoto, M. M., & Wayne, M. L. (2021) · Genome Biology and Evolution · doi:10.1093/gbe/evab240 · Cited by 55
Duintjer Tebbens, R. J., & Thompson, K. M. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit838 · Cited by 48
Bessaud, M., Joffret, M., Blondel, B., & Delpeyroux, F. (2016) · Scientific Reports · doi:10.1038/srep38831 · Cited by 53
Evidence of structural genomic region recombination in Hepatitis C virus.
Cristina, J., & Colina, R. (2006) · Virology Journal · doi:10.1186/1743-422x-3-53 · Cited by 50
“The recombination break-points for non-segmented positive-strand RNA viruses, such as polioviruses and other picornaviruses [ 35-37 ] as well as members of the family Flaviviridae, are often located in the part of the genome encoding non structural proteins.”
BackgroundSanders, B. P., Edo-Matas, D., Custers, J. H. H. V., Koldijk, M. H., Klaren, V., Turk, M., Luitjens, A., Bakker, W. A. M., UytdeHaag, F. G. C. M., Goudsmit, J., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.070 · Cited by 54
Recurrent and Sustained Viral Infections in Primary Immunodeficiencies
Ruffner, M. A., Sullivan, K. E., & Henrickson, S. E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00665 · Cited by 53
“Vaccine-associated poliomyelitis can be due to infection of an immune deficient individual and spread to the CNS or to revertants of vaccine-strain virus (129, 130).”
BackgroundRisk Management in a Polio‐Free World
Aylward, R. B., Sutter, R. W., Cochi, S. L., Thompson, K. M., Jafari, H. S., & Heymann, D. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00840.x · Cited by 51
“Further investigation is needed into the origins and implications of “ambiguous” VDPVs (aVDPVs), for which typically a single representative virus is isolated from a clinical or environmental source, to determine whether additional measures or strategies are needed to manage such viruses.( 19 )”
BackgroundSelf-citationDominant drug targets suppress the emergence of antiviral resistance
Tanner, E. J., Liu, H., Oberste, M. S., Pallansch, M. A., Collett, M. S., & Kirkegaard, K. (2014) · eLife · doi:10.7554/elife.03830 · Cited by 46
“Virus strains and antiviral compounds Poliovirus strains were either Mahoney type 1 poliovirus or the vaccine-derived type 1 Hispaniola strain (Kew et al., 2002).”
BackgroundSelf-citationIdentification of vaccine-derived polioviruses using dual-stage real-time RT-PCR
Kilpatrick, D. R., Ching, K., Iber, J., Chen, Q., Yang, S.-J., De, L., Williams, A. J., Mandelbaum, M., Sun, H., Oberste, M. S., et al. (2014) · Journal of Virological Methods · doi:10.1016/j.jviromet.2013.11.017 · Cited by 45
“…majority of cVDPVs are vaccine/ nonvaccine recombinants having some or all of their noncapsid sequences derived from species C human enteroviruses (Kew et al., 2002; Rousset et al., 2003; Shimizu et al., 2004; Kew et al., 2005; Centers for Disease Control and Prevention, 2012), whereas iVDPVs…”
BackgroundMethodSelf-citationLi, C., Wang, H., Shi, J., Yang, D., Zhou, G., Chang, J., Cameron, C. E., Woodman, A., & Li, Y. (2019) · Journal of Virology · doi:10.1128/jvi.00576-19 · Cited by 47
“For example, the live attenuated Sabin vaccine strain is known to recombine with cocirculating species C enterovirus, where subsequent infection can lead to pathogenic outcomes (20, 21).”
BackgroundHidalgo, S., Erro, M. G., Cisterna, D., & Freire, M. C. (2003) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000069792.60744.5b · Cited by 44
Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future
Patel, M. M., & Cochi, S. L. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix117 · Cited by 46
“Dozens of similar outbreaks have been reported worldwide since the first well-documented, confirmed outbreak of VDPV in Hispaniola, in 2000 [10, 39, 40].”
ResultSelf-citationPolio endgame risks and the possibility of restarting the use of oral poliovirus vaccine
Tebbens, R. J. D., & Thompson, K. M. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1506333 · Cited by 49
Biochemical and genetic analysis of the role of the viral polymerase in enterovirus recombination
Woodman, A., Arnold, J. J., Cameron, C. E., & Evans, D. J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw567 · Cited by 43
“Both phases are necessary for the generation of genomelength recombinants that circulate in the population (7,10).”
Predicting Intraserotypic Recombination in Enterovirus 71
Woodman, A., Lee, K.-M., Janissen, R., Gong, Y., Dekker, N. H., Shih, S., & Cameron, C. E. (2018) · Journal of Virology · doi:10.1128/jvi.02057-18 · Cited by 44
“This result gave rise to the assumption that G-C-rich sequence regions or CpG/ApU dinucleotide bias may trigger RdRp template switching, as previous studies suggest (9, 41).”
BackgroundResultLaassri, M., Dragunsky, E., Enterline, J., Eremeeva, T., Ivanova, O., Lottenbach, K., Belshe, R., & Chumakov, K. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.6.2886-2894.2005 · Cited by 43
“Prolonged circulation of VDPVs in inadequately immunized populations has led to outbreaks of poliomyelitis in Egypt (49, 54), the Philippines (48), the Dominican Republic and Haiti (25, 29), and Madagascar (40), which were caused by highly divergent VDPV strains.”
BackgroundMethodInfluentialA developing country perspective on vaccine-associated paralytic poliomyelitis.
John, T. J. (2004) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862004000100011 · Cited by 54
Lai, Y. A., Chen, X., Kunasekaran, M. P., Rahman, B., & MacIntyre, C. R. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101508 · Cited by 42
Bailly, J., Mirand, A., Henquell, C., Archimbaud, C., Chambon, M., Regagnon, C., Charbonné, F., & Peigue‐Lafeuille, H. (2010) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2010.06.019 · Cited by 48
Odoom, J. K., Yunus, Z., Dunn, G., Minor, P. D., & Martín, J. (2008) · Journal of Virology · doi:10.1128/jvi.00468-08 · Cited by 43
“recently been reported in Hispaniola (26), the Philippines (60),”
BackgroundPolio: from eradication to systematic, sustained control
Razum, O., Sridhar, D., Jahn, A., Zaidi, S. A., Ooms, G., & Müller, O. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2019-001633 · Cited by 42
“But none of these apply to polio: several doses of OPV are needed to convey immunity in low-hygiene settings; and the virus may have been spreading for some time before clinical cases are diagnosed.16 Moreover, the problem of cVDPV has only been realised in the year 2000 when it was first detected on Hispaniola.17 In…”
BackgroundInfluentialPolio Eradicators Use Integrated Analytical Models to Make Better Decisions
Thompson, K. M., Tebbens, R. J. D., Pallansch, M. A., Wassilak, S. G. F., & Cochi, S. L. (2015) · INFORMS Journal on Applied Analytics · doi:10.1287/inte.2014.0769 · Cited by 41
“, Haiti and the Dominican Republic), the CDC documented the ability of OPV to revert back toward both the neurovirulence and transmissibility of WPVs (Kew et al. 2002).”
BackgroundSelf-citationDiop, O. M., Kew, O. M., de Gourville, E. M., & Pallansch, M. A. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix092 · Cited by 42
“Detection of a poliomyelitis outbreak in Hispaniola caused by circulation of VDPV type 1 viruses [8] caused further changes in the GPLN.”
BackgroundSelf-citationSavolainen, C., Laine, P., Mulders, M. N., & Hovi, T. (2004) · Journal of General Virology · doi:10.1099/vir.0.79897-0 · Cited by 46
“Based on the current analysis, it seems that within-species recombination events are also possible for rhinoviruses, similar to those observed for enteroviruses (Santti et al., 1999; Oprisan et al., 2002; Kew et al., 2002; Lindberg et al., 2003).”
ResultXu, W., & Zhang, Y. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3292-4_10 · Cited by 40
A erradicação da poliomielite em quatro tempos
Verani, J. F. D. S., & Laender, F. (2020) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00145720 · Cited by 65
Self-citationMiller, M. D., Barrett, S. A., & Henderson, D. A. (2006) · Europe PMC (PubMed Central) · Cited by 40
Salvati, A. L., Dominicis, A. D., Tait, S., Canitano, A., Lahm, A., & Fiore, L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2233-2243.2004 · Cited by 44
“Indeed, at least three outbreaks of poliomyelitis caused by highly mutated vaccine strains have been reported so far (7, 8, 24).”
BackgroundArita, M., Iwai, M., Wakita, T., & Shimizu, H. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05225-11 · Cited by 40
Self-citationThe role of routine polio immunization in the post-certification era.
Sutter, R. W., Cáceres, V. M., & Lago, P. M. (2004) · Europe PMC (PubMed Central) · Cited by 40
Self-citationVirulence of mixed fungal infections in honey bee brood
Vojvodic, S., Boomsma, J. J., Eilenberg, J., & Jensen, A. B. (2012) · Frontiers in Zoology · doi:10.1186/1742-9994-9-5 · Cited by 40
“Conflict between co-infecting strains can lead to different withinhost dynamics, with consequences for virulence, transmission and host resistance [4,5].”
Vinjé, J., Gregoricus, N., Martín, J. E.-S., Gary, H. E., Cáceres, V. M., Venczel, L., Macadam, A. J., Dobbins, J. G., Burns, C. C., Wait, D. A., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/382545 · Cited by 43
“The outbreak in Hispaniola demonstrated that low levels of vaccine coverage, in combination with poor surveillance of AFP, could result in undetected and prolonged circulation of cVDPV in a community for up to 2 years before cases of poliomyelitis emerge [2].”
BackgroundMethodResultInfluentialSelf-citationThe Evolution of Pathogen Virulence in Response to Animal and Public Health Interventions
Read, A. F., Gandon, S., Nee, S., & Mackinnon, M. J. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511546259.012 · Cited by 45
“There is extremely good evidence for strain differences in virulence, and this seems to have been the raw material that fueled substantial virulence evolution (Witter 1997a,b, 1988, 2001; Kreager 1998; Biggs 2001).”
Multiplex PCR Method for Identifying Recombinant Vaccine-Related Polioviruses
Kilpatrick, D. R., Ching, K., Iber, J., Campagnoli, R., Freeman, C. J., Mishrik, N., Liu, H.-M., Pallansch, M. A., & Kew, O. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.9.4313-4315.2004 · Cited by 39
“None of the cVDPV isolates from the outbreaks in Egypt (30 isolates), Hispaniola (31 isolates), the Philippines (4 isolates), and * Corresponding author.”
MethodInfluentialSelf-citationPoliovirus Vaccine Shedding among Persons with HIV in Abidjan, Cote d’Ivoire
Hennessey, K. A., Lago, H., Diomande, F., Akoua‐Koffi, C., Caceres, V. M., Pallansch, M. A., Kew, O. M., Nolan, M., & Zuber, P. L. F. (2005) · The Journal of Infectious Diseases · doi:10.1086/498166 · Cited by 39
Self-citationVaccine derived bi- and multi-recombinant Sabin strains
Paximadi, E., Karakasiliοtis, I., Bolanaki, E., Krikelis, A., & Markoulatos, P. (2006) · Virus Genes · doi:10.1007/s11262-006-0071-y · Cited by 40
Polio control after certification: major issues outstanding.
Fine, P., Oblapenko, G., & Sutter, R. W. (2004) · Europe PMC (PubMed Central) · Cited by 38
Self-citationBiochemical characterization of the fidelity of poliovirus RNA-dependent RNA polymerase
Freistadt, M. S., Vaccaro, J. A., & Eberle, K. E. (2007) · Virology Journal · doi:10.1186/1743-422x-4-44 · Cited by 38
“The fidelity values derived here for PV 3Dpol are much higher than would be predicted by poliovirus sequence variation rates (while evolving in human populations), which is about 0.02 mutations per year [ 33 ].”
BackgroundInfluentialAn epidemiological analysis of Acute Flaccid Paralysis (AFP) surveillance in Kenya, 2016 to 2018
Tesfaye, B., Sowe, A., Kisangau, N., Ogange, J., Ntoburi, S., Nekar, I., Muitherero, C., Camara, Y., Gathenji, C., Langat, D., et al. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05319-6 · Cited by 39
Isolation of vaccine-derived polioviruses in the Slovak Republic
Cernakova, B., Sobotová, Z., Rovný, I., Blahova, S., Roivainen, M., & Hovi, T. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-1331-9 · Cited by 36
Homologous recombination evidence in human and swine influenza A viruses
He, C.-Q., Han, G., Wang, D., Liu, W. Y., Li, G.-R., Liu, X., & Ding, N. (2008) · Virology · doi:10.1016/j.virol.2008.07.014 · Cited by 36
Dufresne, A. T., & Gromeier, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403998101 · Cited by 38
Tebbens, R. J. D., & Thompson, K. M. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1114-6 · Cited by 36
“However, in places with very low population immunity to transmission, OPV can evolve to acquire WPV-like properties and cause outbreaks of circulating vaccine-derived poliovirus (cVDPV) [6–8].”
Background
Metadata
- Authors
- Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., Sutter, R., Tambini, G., Venczel, L., Pedreira, C., Laender, F., Shimizu, H., Yoneyama, T., Miyamura, T., van der Avoort, H., Oberste, M. S., Kilpatrick, D., Cochi, S., Pallansch, M., & de Quadros, C.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Caribbean Epidemiology Centre (CAREC) Laboratory, Pan American Health Organization (PAHO), 16-18 Jamaica Boulevard, Federation Park, Port-of-Spain, Trinidad and Tobago.
- World Health Organization Regional Office for the Americas (US)
- Ministry of Health, Avenida San Cristóbal esquina Tiradentes, Santo Domingo, Dominican Republic.
- Ministry of Public Health, Port-au-Prince, Haiti.
- PAHO, Calle Pepillo Salcedo, Plaza de la Salud, Santo Domingo, Dominican Republic.
- PAHO, Number 295 Avenue John Brown, Port-au-Prince, Haiti.
- National Institute of Infectious Diseases (JP)
- Polio Laboratory, National Institute of Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3720 BA, Bilthoven, Netherlands.
- Division of Vaccines and Immunization, PAHO, 525 Twenty-Third Street, N.W., Washington, DC 20037, USA.
- Corresponding author
- Kew, Olen
- ORCID
- Venue
- Science
- Published
- 2002-04-12
- Volume
- 296
- Issue
- 5566
- Pages
- 356-359
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2101037145
- Cited by
- 600
- References
- 19
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 15 · 2023: 19 · 2022: 20 · 2021: 15 · 2020: 17 · 2019: 17 · 2018: 21 · 2017: 21 · 2016: 26 · 2015: 22 · 2014: 39 · 2013: 26 · 2012: 26
- FWCI
- 25.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- poliomyelitis outbreak, vaccine-derived poliovirus, poliovirus type 1, oral polio vaccine, Hispaniola, Dominican Republic, Haiti, unvaccinated children, low vaccination coverage, paralytic poliomyelitis, wild poliovirus
- MeSH terms
- Adolescent, Animals, Capsid, Child, Child, Preschool, Disease Outbreaks, Dominican Republic, Female, Genes, Viral, Haiti, Humans, Infant, Male, Molecular Sequence Data, Poliomyelitis, Poliovirus Vaccine, Oral, Population Surveillance, Recombination, Genetic, Vaccination, Virulence, Point Mutation, Immunization Programs, Poliovirus, 5' Untranslated Regions, Capsid Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.